University of Houston: Treatment for Deadly Superbug C. Diff May Be Weakening
April 26, 2024
April 26, 2024
HOUSTON, Texas, April 26 (TNSres) -- The University of Houston issued the following news:
* * *
As Popularity of Vancomycin Increases, Effectiveness Wanes
* * *
By Laurie Fickman
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from the University of Houston College of Pharmacy.
* * *
As Popularity of Vancomycin Increases, Effectiveness Wanes
* * *
By Laurie Fickman
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from the University of Houston College of Pharmacy.